The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
Implements methods for inference on potential waning of vaccine efficacy and for estimation of vaccine efficacy at a user-specified time after vaccination based on data from a randomized, double-blind, placebo-controlled vaccine trial in which participants may be unblinded and placebo subjects may be crossed over to the study vaccine. The methods also for variant stratification and allow adjustment for possible confounding via inverse probability weighting through specification of models for the trial entry process, unblinding mechanisms, and the probability an unblinded placebo participant accepts study vaccine.
| Version: | 1.4 |
| Depends: | R (≥ 3.5.0), survival, stats, graphics, ggplot2, Rcpp, RcppArmadillo, methods |
| LinkingTo: | Rcpp, RcppArmadillo |
| Published: | 2023-12-13 |
| Author: | Marie Davidian [aut], A.A. Tsiatis [aut], Shannon T. Holloway [aut, cre] |
| Maintainer: | Shannon T. Holloway <shannon.t.holloway at gmail.com> |
| License: | GPL-2 |
| NeedsCompilation: | yes |
| Materials: | NEWS |
| CRAN checks: | VEwaningVariant results |
| Reference manual: | VEwaningVariant.pdf |
| Package source: | VEwaningVariant_1.4.tar.gz |
| Windows binaries: | r-devel: VEwaningVariant_1.4.zip, r-release: VEwaningVariant_1.4.zip, r-oldrel: VEwaningVariant_1.4.zip |
| macOS binaries: | r-release (arm64): VEwaningVariant_1.4.tgz, r-oldrel (arm64): VEwaningVariant_1.4.tgz, r-release (x86_64): VEwaningVariant_1.4.tgz, r-oldrel (x86_64): VEwaningVariant_1.4.tgz |
| Old sources: | VEwaningVariant archive |
Please use the canonical form https://CRAN.R-project.org/package=VEwaningVariant to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.